Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Comparison of Intraosseous Anesthesia and Inferior Alveolar Nerve Block for Primary Mandibular Molars

NCT07846098 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-14
Last updated
2026-09-29

Condition(s) studied

PainDental Caries

Investigational drug(s) / intervention(s)

Inferior Alveolar Nerve Blockintraosseous anaesthesia

Inferior Alveolar Nerve Block: inferior alveolar nerve block using Articaine 4% with 1/200000 Adrenaline and a traditional needle injection

intraosseous anaesthesia: intraosseous anaesthesia using Articaine 4% with 1/200000 Adrenaline and a special intraosseous injection device

Study summary

The aim of the present study is to compare computerized intra-osseous injection system to the conventional inferior alveolar nerve block in primary mandibular teeth.

Eligibility

Sex
ALL
Min age
6 Years
Max age
8 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 6 to 8 years * Systemically healthy (American Society of Anesthesiologists \[ASA\] physical status I) * Positive or definitely positive behavior (Frankl Behavior Rating Scale score 3 or 4) * Bilateral (contralateral) mandibular primary molars with deep dentin caries requiring treatment * Able to attend a second appointment * Written informed consent from a parent/legal guardian and assent from the child Exclusion Criteria: * Known allergy to local anesthetic solutions * Use of analgesics within the last 24 hours * Acute infection * Gingivitis, oral fistula, abscess, or bone loss in the area where anesthesia will be administered

Primary outcome measure(s)

  • Pain Intensity Measured by Visual Analog Scale (VAS) — Immediately after anesthetic injection and during dental treatment (Day 1)
    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst possible pain). Scores range from 0 to 10, with higher scores indicating greater pain.

Trial sites (1)

FacilityCityRegionStatus
Sivas Cumhuriyet University Sivas Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07846098 on ClinicalTrials.gov ↗ ← All trials in Turkey